2021 Pediatric Grand Rounds | Rh Blood Group and the Significance of RHAG Mutation

Duarte, CA US
May 13, 2021

Molecular advances in benign hematology (Rh blood group incompatibilities or RHAG mutations) can offer novel insights that can impact care. While recognition of an incompatibility and treatment have become standard practices in newborn management, the expected course of the disease varies depending on the etiology.  Currently, several multigene panels must be sent out to diagnosis etiology of incompatibility, but advances in NGS technology allow a single test to return results that can be utilized for patient management. 

Benign hematologic conditions can impact management in pediatric oncology care.  The purpose of this lecture is to update practitioners of malignant conditions with advances in benign hematologic conditions, such as Rh blood group incompatibilities or RHAG mutations. 

Target Audience

City of Hope Pediatric Hematology/Oncology physicians, advance practice practitioners, City of Hope staff and research teams.

Learning Objectives

  • Distinguish anemias caused by benign hereditary hemolytic anemia, specifically Rh blood group incompatibilities or RHAG mutations, from malignant hematology.
  • Demonstrate ability to work up molecular causes of hereditary hemolytic anemia.
  • Integrate benign hematology management (Rh blood group incompatibilities or RHAG mutations) with malignant hematology management.
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2021 Pediatric Grand Rounds | Rh Blood Group and the Significance of RHAG Mutation for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Activity opens: 
05/13/2021
Activity expires: 
05/14/2021
Event starts: 
05/13/2021 - 12:00pm
Event ends: 
05/13/2021 - 1:00pm
City of Hope
1500 E Duarte Rd
Duarte, CA 91010
United States

Virtual Meeting- Zoom

Clarke Anderson, MD   Assistant Professor, Department of Pediatrics; City of Hope

Dr. Anderson has indicated that he does not have anything to disclose. 

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live webinar for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

 AMA PRA Category 1™  1.0

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2021 Pediatric Grand Rounds | Rh Blood Group and the Significance of RHAG Mutation for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Please login or register to take this activity.